Site Logo
An update from the AVROBIO advocacy team
2020-03-25 13:03:02

"Given the healthcare resources required to manage COVID-19, a number of clinical trial sites worldwide have temporarily postponed elective procedures, including clinical trial activities. While we remain committed to moving our clinical programs forward, AVROBIO supports this temporary reallocation of resources to ensure hospitals can focus on meeting the needs of patients with COVID-19. We are monitoring the situation closely and are working to develop contingencies, such as virtual monitoring, for ongoing trial participation. We will also continue to identify interested and potentially eligible patients via remote screening so sites can resume in-person screening and enrolment as soon as it is appropriate."